Tara Donnelly is the interim Chief Digital Officer at NHS England.

She oversees a portfolio of citizen facing digital services, including the NHS website, NHS App and the development of digital services which meet people’s needs, target prevention and offer a personalised experience.

Tara is on secondment from her role as Chief Executive of the Health Innovation Network. She has led the Health Innovation Network for over three years and is also a non-executive director at the Nuffield Trust.

She has an extensive background in leadership roles within the NHS and the voluntary and community sector and has spent the past 18 years at board level. She has worked in the NHS for 30 years, with her first role being as a Ward Housekeeper when she was 18.

Alan Karthikesalingam is a Senior Clinician Scientist at DeepMind Health, leading the translation between our Health Research and Streams teams. After studying medicine at the University of Cambridge, Alan trained in vascular and endovascular surgery in London, Lille and New York. At St George’s University of London, he completed his PhD and led a successful research group investigating neural networks for medical imaging, new approaches to randomised trials, and the use of routine data to understand care. Alongside clinical practice, he published over 125 peer-reviewed papers, including award-winning first-author studies in the Lancet and the New England Journal of Medicine. Prior to joining DeepMind, he co-launched an app still in use across the London Ambulance Service in a study of vascular emergency Triage.

Dr. Wei Fan is the executive director of Tencent Hippocrates Labs. His main interests are in using various artificial intelligence techniques-based digital therapeutics & digital biomarker for clinical problems, such as motion disorder syndrome (e.g., Parkinson’s disease), cancer radiotherapy planning, heart failure early detection, etc. Dr. Fan received Ph. D. in Computer Science from Columbia University. He has been working in AI since 1995. He has over 150 top journals and conference papers with h-index of 58. He has received multiple best paper awards in top AI conferences and competitions. He served as the associate editor of ACM Transaction on Knowledge Discovery and Data Mining.

Prof. Dr. med. Mathias Goyen is currently the Chief Medical Officer Europe for GE Healthcare, a $19billion division of General Electric. Mathias is responsible for leading GE Healthcare’s medical, clinical and evidence generation strategies for product modalities in Europe. Together with his team he provides leadership in healthcare economics and outcomes research and comparative effectiveness research to develop customer value propositions for new and existing products Mathias began his career as a diagnostic Radiologist working at Essen and Hamburg/Germany. He was appointed Professor of Diagnostic Radiology at the University of Hamburg/Germany in 2010. Mathias’previous experience also includes 5 years as Managing Director of UKE Consult and Management GmbH, a subsidiary of the University Medical Center Hamburg where he was responsible for the overall consulting and foreign business of the University Medical Center Hamburg. Together with the leadership team of the hospital Mathias established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies. Mathias holds a medical degree from the University of Bochum, Germany. He has been secretary general of the German-Chinese Society of Medicine, Berlin, since 2005. Mathias lives in Essen/Germany with his family.

Stephanie is an NHS Clinical Entrepreneur and Senior Research Fellow at UCL and UCLH where she was awarded a Doctorate in Clinical Research in Oncology. Research Interests include Integrated Data Models for Cancer Monitoring, Survivorship and Longevity. A Clinician-Scientist with over 10 years experience, Stephanie has served on council on a National Cancer Society (BGCS) and is the Healthcare Ambassador of the global organisation Women in AI (WAI). She is a Scientific Advisor to WILD.AI and the Havas Lynx Faculty and on the Advisory Committee of the Social Impact Community, the Conduit, London.

Dr Marc Farr started his career at Experian, where he was head of public sector consulting. He went on to become head of development at Dr Foster, and has been director of information at East Kent Hospitals University NHS Foundation Trust for seven years. He is also founder and chief executive of Beautiful Information.

Beautiful Information is a first of kind NHS / private partnership, that delivers real time information to NHS trusts to help them plan and resource clinical services. It’s vision is to connect patients, clinicians and managers through beautiful information, to make healthcare simple and transparent.

Fernanda is an Ophthalmologist working at two private practices where she is running several studies integrating healthcare and clinical practice to AI. She is also working as a Medical Consultant for Deep Cube’s Glaucoma Algorithm. Fernanda is part of the Surgical Retina Fellowship at HUPE where she also supervises Ophthalmology Medical Residents and is recently running news studies about eye diagnostics with artificial intelligence. 

Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry. Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain.

Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare.

Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.

Dr. Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation Trust, with a sub-specialist interest in breast cancer screening. She is leading trust wide research collaboration to implement novel artificial intelligence software for improved patient outcomes. She has been appointed as AI Clinical Lead and is responsible for implementation and adoption of Artificial Intelligence practice within the Trust, working in conjunction with various stakeholders with a mission statement of patient-focused value-based healthcare.

I am a research focussed clinical scientist, working in advanced imaging and image processing for radiotherapy.

My interests include translating cutting-edge methods into routine clinical practice and maximising patient benefit through digital technology, particularly artificial intelligence. Robustness is critical for novel digital technologies in the health sphere, to enable safe and effective uptake of AI.

My clinical work involves imaging patient motion during radiotherapy. Before changing career into radiotherapy I was a chemical physicist working in academic research. I enjoy the outdoors and live in Leeds with my wife and two boys.

Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally.

Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

As a board executive for i2i events (parent company The Guardian Media Group / Apax – Ascential – previously Top Right Group) with the specific remit to rapidly grow the business whilst leveraging operational costs and prepare pre IPO. She sat on the i2i mergers and acquisitions committee identifying, analysing and approaching target businesses and accelerated growth by 22% within 12 months.

Achievements include the launch and acquisition of Money 2020 – a leading fintech product. This included negotiation, 3 stage due diligence, its subsequent integration, and the long term geo-adaption into a global portfolio worth over $40m. The launch of World Retail Congress in 10 countries, the re-launch of Cannes Lions festival.

Sarah is a regular keynote speaker on start-ups, business and women / equality related issues and is an ambassador for the Royal Marsden where she champions the use of AI tech in oncology advances.

I am a registered clinical scientist working as a magnetic resonance physicist at Guy’s & St. Thomas’ NHS FT after having graduated from the NHS Scientist Training Programme.

Following a successful NHS Digital Pioneer Fellowship with DigitalHealth.London, I have recently been appointed as Digital Lead for the Clinical Imaging and Medical Physics directorate at my Trust, where we have begun work to develop an evaluation framework for clinical AI.

I am also a part-time PhD candidate at the Centre of Neuroimaging Sciences at King’s College London, developing a machine learning model to better evaluate treatment response in glioblastoma patients.

Sameena Ali-Khan anchors national bulletins for ITV at weekends, and throughout the week on Central Tonight in the Midlands, covering a wide range of stories across daily news and documentaries.

After studying Physiology and Chemistry, Sameena was drawn to journalism. After working on radio in Manchester she first appeared on air on BBC Radio Lancashire. She remained with the BBC, going back to Manchester and GMR before stints on the BBC Asian Network, BBC West Midlands and BBC London, as well Radio 5Live. On TV (aside from a debut appearance made whilst living in Nigeria on the country’s equivalent of Blue Peter) Sameena presented and reported for Northwest Today, Inside Out, and Midlands Today before moving to ITV.

With a presenting style combining bright and approachable with authoritative, Sameena is the only presenter to have won the RTS Best On Screen Personality two years running.

David Chung is the USA Head of Carewell Lepu Medical. A strategic partner of Intel Builders AI program. A patient turned AI technologist, an experienced manager with awareness of the application of digital technology in a range of sectors. David has worked in the healthcare IT sector since 2007, member of ALA, AHIMA leading strategic guidance on data backup, migration, business process outsource, reimbursement audit and workflow optimization.
Prior to Lepu Medical, he oversees millions of medical record data exchange in four States, responsible or $18M P&L as the technology transitioned into artificial intelligence processing. With diverse experience in the artificial intelligence legal services, he’s keen on the possibility of AI.
David is responsible for the global adoption of AI-ECG. And has successfully launched USA’s first AI-ECG enabled telemedicine platform, trained on 47 million patients heart ECG data.
With a sister that suffers from congenital heart disease. David is passionate on expanding the possibility of AI in challenging applications for better patient outcomes.

Joe has worked in healthcare IT since 2004 when he joined the first NHS Spine project as part of the National Programme for IT. He often says that since then he has been making up for the sins of the past. Today he advises everyone from the boards of the central NHS bodies to local charities and healthcare organisations on the best way to approach technology change and the best way to harness its potential to provide actual benefits for patients and health services.

John manages the clinical aspects of the company’s operations including legislation, information governance, clinical safety and ensuring TPP’s products reflect the latest medical practice.

Dr Parry graduated from the University of Cambridge with a medical degree in 1980. He moved to Yorkshire in 1984 to take a position as a partner of Keighley Health Centre, specialising in oncology and palliative care. He was an early user of SystmOne and recognised the benefits clinical IT could bring to the delivery of patient care. As a result, Dr Parry took the role of clinical lead at TPP, directing the clinical aspects of all products throughout the development process. He holds relationships with leading medical representatives around the country to make sure TPP’s company priorities align with those of the wider clinical community. John became a Director in 2007 and now leads a team of expert clinicians, ensuring TPP’s products meet the requirements of health services.

Dr Parry’s expertise as a healthcare specialist is nationally recognised. He is a member of various high-level committees, including the TechUK Health and Social Care board. As a leading clinician, he is frequently invited to give keynote speeches on a wide range of topics, including information governance and the role of IT in patient care.

Naomi Lee is a Senior Executive Editor at the leading medical journal The Lancet. She has responsibility for research, leading the development and implementation of the research strategy for The Lancet, and advising on the research content of the other journals in The Lancet family of journals. Naomi handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, digital medicine/AI, and medical technology. She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health.

Naomi joined The Lancet in 2014 and was previously the Executive Editor (Digital) where alongside editorial work she led the internal and external digital transformation of The Lancet group. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the United Kingdom. She has completed fellowships in Argentina, and Mexico. She has also studied data science at University College London.

Erik de Heus has been at the helm of SkinVision as CEO since 2017. With over 20 years of global experience, Erik has both the breadth of experience and proven knowledge to drive the health tech company’s mission forward.

Throughout his previous work within Hewlett-Packard and Royal Philips Electronics, he has experience building new products and services with a global scope. For Hewlett-Packard, he worked and lived in Geneva and Mountain View. In various management positions, working across cultures with different corporate and entrepreneurial teams, he created and managed different solutions in the technology, finance, services, health, and wellbeing spaces.

In addition to this global experience, Erik was CEO of a Dutch renewable energy company Oxxio. Under his management, the company grew in the timeframe from inception to generate over € 500,000,000. In the buy and build strategy, Oxxio acquired and integrated four companies in two years. OXXIO was acquired in 2005 by Centrica Preventing an IPO planned for mid-2005. Erik holds a Master degree in Business Economics from the Free University of Amsterdam.

Emma is an experienced innovation business leader, with proven track record of strategic and operational implementation of innovation methodology, services and cultural change within global small and large organisations. Emma is a collaborative, open communicator with 23 years international business experience, working since 2001 at the forefront of open innovation process development, understanding the importance of organisational, technical and commercial considerations for successful innovation strategy deployment.

Dr Indra Joshi is the acting Director of AI for NHSX, leading on the creation of the NHS AI Lab. Her other responsibilities include overseeing digital health initiatives within the NHS with a focus on data, digital health standards and evidence.

Indra has a unique portfolio with experience stretching across policy, digital health, national project strategy and implementation; whilst remaining true to her professional training as an emergency medic.

She is a Founding Member of One HealthTech – a network which campaigns for the need and importance of better inclusion of all backgrounds, skill sets and disciplines in health technology. Alongside she is a Vice-Chair for the British Computer Society (Health), an international speaker and consultant on digital health, an expedition medic, and most importantly a mum to two wonderful little munchkins.

Kevin Goodwin is a 32 year veteran innovator from the global ultrasound business. In 1998 he founded Sonosite, the world’s first ultrasound company to miniaturize & simplify ultrasound technology. Today, Kevin is engaged in another first: applying artificial intelligence to recognize anatomy and quickly guide medical practitioners of all skill levels in easily looking into the body, and to make more accurate diagnostic assessments in just seconds. In 2015, Kevin co-founded EchoNous for the purpose of creating intelligent medical tools with extremely miniaturized, diagnostic grade technology.

Dr Allison Gardner is a Teaching Fellow at Keele University and Programme Director for the Science Foundation Year. She teaches Bioinformatics in the School of Computing and supervises PhD and third year project students. Her research is focused on utilization of machine learning to predict disease, gender and computing, AI ethics and governance of AI.
She works on the IEEE P7000 Global Initiative on the Ethics of Autonomous and Intelligent Systems and specifically P7003 on algorithmic bias, providing a framework for Algorithmic Impact Assessments. Allison speaks nationally on AI Ethics, machine bias and the need for diversity and regulation in the field of AI. She has acted as a consultant for a variety of companies on their AI ethics panels.
Allison is a local councillor and an experienced chair and campaigner. She chairs the Conservation Advisory Working Party, sits on the Economic Development and the Health scrutiny committees and is a school governor. She is an alumnus of the first cohort of the Jo Cox Women in Leadership Programme.

Oliver Smith is the Strategy Director & Head of Ethics at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

Oliver propels Alpha Health’s strategy development, establishing and maintaining strong partnerships to further its mission to deliver breakthrough solutions which address the greatest challenges in the healthcare sector worldwide. In addition, Oliver is the Head of Ethics at Alpha Health, ensuring the total trust of users is at the very centre of the Moonshot’s operations.

Prior to joining Alpha Health in 2016, Oliver worked as the Director of Strategy and Innovation at Guy’s and St Thomas’ Charity, Deputy Director of Health and Wellbeing at the Department of Health and as a Policy Advisor to the Prime Minister’s Strategy Unit.

Tarek R. Besold, PhD, is the Chief Behavioural Officer at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

At Alpha Health, Tarek offers strategic leadership at the intersection between AI, behavioural science, and the design of digital products. Tarek leads a team of 25 full-time engineers to identify opportunities where behavioural science could be applied to improve or change user behaviour in line with Alpha Health’s strategy and roadmap.

Before joining Telefonica Innovation Alpha, he was a Lecturer/Assistant Professor in Data Science at City, University of London, conducting research at the intersection between artificial intelligence, computational creativity, and cognitive systems.

Among others, Tarek was the General Chair of the HLAI 2016 and 2018 Joint Multi-Conferences on Human-Level Artificial Intelligence, and founder and organiser of several international workshop series bridging between AI and cognitive science. He was co-editor of the books Computational Creativity Research: Towards Creative Machines and Concept Invention: Foundations, Implementations, Social Aspects and Applications. In addition, Tarek holds different editorial functions with several scientific journals in AI and neighbouring fields (including Cognitive Systems Research and the Journal of Artificial General Intelligence).

Tarek also serves as chairman of the German Institute for Standardization (DIN)’s National Working Group on Standards and Norms for AI (part of the ISO/IEC JTC-1 SC 42 “Artificial Intelligence”), and as an expert member of the Digital Future Society’s Think Tank Working Group on “Data Ethics and the Challenge of Digital Privacy”.

Christian is Co-founder and Chief Technical Officer of Edge Health. He leads the development of data products that help operational and clinical teams make evidence-based decisions and improve their effectiveness.

Samantha Roberts has recently been appointed as Chief Executive of the Accelerated Access Collaborative, the national umbrella organisation for health innovation, hosted in NHS England and NHS Improvement.

She originally trained as a doctor and practiced medicine in South Africa, the UK, and Australia before undertaking an MBA and joining McKinsey and Company, where she worked in a wide range of industries before specialising in healthcare.

After McKinsey she moved into the NHS as a senior manager at a large teaching hospital in London (UCLH) and a director in an Academic Health Sciences Centre and Network (UCLPartners). Before taking on the role of Director of Innovation, Research and Life Sciences at NHS England and NHS Improvement last year.

Over the last five years she has become involved in research, working with health economic models to inform evidence-based policy, initially at the London School of Economics before moving to the University of Oxford to undertake a DPhil (PhD).

Christina is an innovation senior manager at NHS England and NHS Improvement. After working for many years as an adult nurse specialising in critical care, Christina moved to a quality improvement and patient safety role in an acute Trust, particularly developing the Women and Children’s service. In 2018 Christina joined the Innovation, Research and Life sciences team supporting innovation programmes which challenge traditional ways of working to improve patient care. Christina’s MSc in Implementation and Improvement Science and recent work have led her to focus on the factors which affect successful adoption and spread of innovation into healthcare, covering a wide
range of innovations including MedTech, diagnostic, digital and AI solutions. Christina leads the AI Award delivery team: the team supports the AAC ambition to improve the pipeline for innovations which meet the needs of patients and the National Health Service.

Victoria has over a decade of experience in the semiconductor space. She currently heads up Strategic Partnerships at Graphcore, working with key customers and leading Research & Universities AI engagements. Previously she held several leadership positions at NVIDIA from global alliances, product marketing and campaigns to the founding of the GPU Technology Conference. Prior to joining NVIDIA, Victoria worked in the hedge fund space, as Executive Director for the Hedge Fund Business Operations Association. Victoria is a frequent contributor to ACM SIGGRAPH and is AR, MR & VR Chair for the SIGGRAPH 2019 Conference. She’s also an active member of the Consumer Technology Association’s AI Working Group.

Laurence Thorne is the policy manager for AI within NHSX and is supporting the development and delivery of the NHS AI Lab. Previously, Laurence has led the procurement and delivery of digital and transformation projects across government including in education, transport and health.

Ian is actively involved in the NIHR i4i Programme, SBRI Healthcare and now the AI in Health and Care Award along with Medtech SME engagement, managing a portfolio of funded projects and the NIHR Innovation Observatory contract. A DPhil in chemistry led to Ian becoming a Principal Scientist at Kodak European R&D, followed by 9 years at GE Healthcare leading the Discovery portfolio for neurological molecular imaging. Ian is a (co-)inventor on 38 patent applications, a Fellow of the Royal Society of Chemistry, a member of UKRI Peer Review College and the External Review Board for CPI Photonics.

Dr Fanny Burrows is a Senior Programme Manager in the Innovation Team at LGC in the NIHR Central Commissioning Facility.
Fanny manages a portfolio of Invention for Innovation (i4i) projects and Small Business Research Initiative (SBRI) Healthcare projects. She also takes responsibilities for sourcing and managing expert members for the review panels and acts as a Patient and Public Involvement Lead.
Prior to working with the NIHR, Fanny spent a few years in a Medtech company, developing and transferring novel materials for applications in medical devices and focused on antimicrobial and haemocompatible coating technologies. Her work involved the research and development of biocompatible technologies, from feasibility stage to regulatory approval and market growth. Fanny was involved in a range of medium to large projects including technology transfer to global medical devices manufacturers.

Jo became involved in the AI Lab in January 2020 focusing on our first AI Health and Care Award. She does this alongside her role as head of office for the chairs of NHS England and NHS Improvement.
She has been working for the NHS for over 6 years now, originally from Australia where she studied both a Bachelor’s of Public Health and Health Promotion as well as a Bachelor of Commerce.
Jo worked in operational roles in Australia, focusing on opening café franchises from Dec 2011 until her move to the UK in July 2013 enjoying working with various stakeholders, building relationships and developing the franchise model.
She lives in Camberwell and loves the diversity and community of London.

With a keen interest in the potential of technology Dan joined NHSX in 2019 to lead implementation of the new NHS AI Lab.
Prior to this Dan spent 10 years managing government programmes including 6 years abroad with the Department for International Development in countries such as Afghanistan and the Democratic Republic of the Congo. Dan has specialised in implementing large health programmes in challenging environments and recently led the design and implementation of a £350m multi-donor programme providing basic health services in South Sudan. When not at work Dan enjoys tormenting his family with the latest smart home technology.

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data. This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

An innovative operational strategy expert with extensive and wide-ranging experience relating to strategic programme leadership, planning and management of clinical trials with responsibility for global clinical programmes (US, Europe and Japan). Peju started her career working in early drug discovery and exploratory phase focused on the transition of early stage assets to clinical development. Following this, she moved into programme management of late stage assets responsible for key clinical programmes within Eli Lilly, Sanofi Aventis, Pfizer and Takeda before joining BenevolentAI as Clinical Development Operations Leader.

Data Partnerships Manager at the Wellcome Trust. Collaborating with data scientists, industry and academia to improve the way data is used in the health sector. Before joining the Wellcome Trust, dawn was a policy adviser at the ODI and help deliver many of our international projects including the Open Data Leaders Network. Dawn is an ODI Registered Trainer with expertise in expertise in data, community building and policy making.

Featured as ‘one to watch’ in a list of top black women working in the UK tech industry as part of the #wherearethefaces initiative.

Reema is a programme manager at the Nuffield Foundation, and is working to establish the Ada Lovelace Institute, an organisation seeking to ensure that data & AI work for people and society. She is an experienced policy professional who has led various citizen engagement and participation initiatives on complex and controversial policy areas in the UK, including the Royal Society of Arts (RSA) Citizens’ Economic Council, which successfully worked with and influenced the Bank of England’s public engagement strategy. Reema has consulted for a variety of international organisations, including the Danish Board of Technology Foundation and Nextdoor.com, San Francisco based technology social media start-up. She is a fellow of the RSA, founding trustee of a community run library, and a local councillor.

Dr Harvey is a radiologist, trained in the NHS and Europe’s leading cancer research institute, the ICR, where he was twice awarded Science Writer of the Year. Previously a consultant radiologist at Guys & St Thomas’, he has held senior positions at two leading AI startups, sat on several national committees for AI in radiology in the UK, and acted as co-chair of the government-commissioned Topol Review into the impact of AI in the NHS. He is currently managing director at digital health consultancy Hardian Health focussed on clinical, regulatory and financial services for the technology sector.